Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Direct Oral Anticoagulant Therapy With the HeartMate 3 LVAD: A Pilot Study

NCT04974684 is registered in ClinicalTrials.gov with Institute for Clinical and Experimental Medicine as lead sponsor.

NCT NCT04974684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04974684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Direct Oral Anticoagulant Therapy With the HeartMate 3 LVAD: A Pilot Study
Lead sponsor
Institute for Clinical and Experimental Medicine
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2022
Completion date
March 1, 2024
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lvad (left ventricular assist device) thrombosis